牛叉诊股

[{"date":"2026.07.07","stock":"-3.14","trade":"-4.17","ind":"-1.26"},{"date":"2026.07.06","stock":"0.57","trade":"0.97","ind":"-0.06"},{"date":"2026.07.03","stock":"0.87","trade":"1.73","ind":"0.37"},{"date":"2026.07.02","stock":"0.15","trade":"1.10","ind":"-2.03"},{"date":"2026.07.01","stock":"1.17","trade":"5.64","ind":"0.44"},{"date":"2026.06.30","stock":"-8.22","trade":"-1.27","ind":"0.50"},{"date":"2026.06.29","stock":"8.80","trade":"5.87","ind":"1.16"},{"date":"2026.06.26","stock":"-4.08","trade":"-4.86","ind":"-2.26"},{"date":"2026.06.25","stock":"-1.80","trade":"-1.35","ind":"0.23"},{"date":"2026.06.24","stock":"-2.16","trade":"-0.89","ind":"0.11"},{"date":"2026.06.23","stock":"3.93","trade":"3.68","ind":"-1.37"},{"date":"2026.06.22","stock":"0.28","trade":"0.07","ind":"1.78"},{"date":"2026.06.18","stock":"1.00","trade":"0.66","ind":"-0.43"},{"date":"2026.06.17","stock":"-0.99","trade":"-1.16","ind":"0.40"},{"date":"2026.06.16","stock":"-1.53","trade":"-0.99","ind":"-0.11"},{"date":"2026.06.15","stock":"0.70","trade":"0.15","ind":"1.61"},{"date":"2026.06.12","stock":"2.29","trade":"2.07","ind":"1.12"},{"date":"2026.06.11","stock":"-1.96","trade":"-1.24","ind":"-0.16"},{"date":"2026.06.10","stock":"0.56","trade":"-0.14","ind":"-0.42"},{"date":"2026.06.09","stock":"-1.25","trade":"0.45","ind":"1.28"},{"date":"2026.06.08","stock":"-1.91","trade":"-2.49","ind":"-1.70"}]

鲁抗医药,上证指数,化学制药指数

压力支撑

该股压力位为6.85元，支撑位为6.73元。

[{"text":"\u538b\u529b\u4f4d","value":"6.85","date":1783353600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.73","date":1783353600,"color":"0x0b52a1"}]

多空趋势

空头行情中，并且有加速下跌的趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.6资金面打败了12%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，主力筹码比10日前集中，现在已低度控盘，投资者可关注。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体无进出。

更新时间：07月08日 08:06

机构今日流向(万元)	-3179.40	机构5日流向(万元)	551.76
机构10日流向(万元)	325.01	机构20日流向(万元)	-534.66

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少75.71万股，其中基金净减仓7家，主力净减仓3家，请投资者中长期谨慎为宜。

截止2025-12-31，共31家主力机构（基金27家，一般法人3家，其他资管计划1家），持仓量总计24383.28万股，占流通A股27.13%
其中，基金持仓与2025-06-30相比：
增仓：2家，增持 25.42万股
减仓：9家，减持 44.69万股
新出现在主力名单中：16家，持有64.34万股
从主力名单中消失：19家，原持有177万股

消息面诊股

诊断结果：5.9消息面打败了57%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-04-25
利好	分红转增	10派0.5元(含税)	2026-04-25
一般消息	募资投向		2026-04-25
一般消息	重大事项	关联交易	2026-04-25
一般消息	募资投向	公司购买资产	2026-04-18
重大利空	业绩预告	业绩大幅下降	2026-01-28
一般消息	重大事项	关联交易	2025-12-31
一般消息	重大事项	关联交易	2025-12-12
利好	股票增发	已实施	2025-12-05
一般消息	高管变动	取消监事会	2025-10-10
一般消息	分红转增	不分配不转增	2025-08-28

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	1条	1条	0条

行业面诊股

诊断结果：7.4行业面打败了98%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2026.07.07","price":"-1.26","value":"-4.17"},{"date":"2026.07.06","price":"-0.06","value":"0.97"},{"date":"2026.07.03","price":"0.37","value":"1.73"},{"date":"2026.07.02","price":"-2.03","value":"1.10"},{"date":"2026.07.01","price":"0.44","value":"5.64"},{"date":"2026.06.30","price":"0.50","value":"-1.27"},{"date":"2026.06.29","price":"1.16","value":"5.87"},{"date":"2026.06.26","price":"-2.26","value":"-4.86"},{"date":"2026.06.25","price":"0.23","value":"-1.35"},{"date":"2026.06.24","price":"0.11","value":"-0.89"},{"date":"2026.06.23","price":"-1.37","value":"3.68"},{"date":"2026.06.22","price":"1.78","value":"0.07"},{"date":"2026.06.18","price":"-0.43","value":"0.66"},{"date":"2026.06.17","price":"0.40","value":"-1.16"},{"date":"2026.06.16","price":"-0.11","value":"-0.99"},{"date":"2026.06.15","price":"1.61","value":"0.15"},{"date":"2026.06.12","price":"1.12","value":"2.07"},{"date":"2026.06.11","price":"-0.16","value":"-1.24"},{"date":"2026.06.10","price":"-0.42","value":"-0.14"},{"date":"2026.06.09","price":"1.28","value":"0.45"},{"date":"2026.06.08","price":"-1.70","value":"-2.49"}]

上证指数,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	花园生物	64.61%	-18.18%	4.3分
2	艾力斯	52.09%	11.90%	6.2分
3	百利天恒	49.75%	4.19%	5.1分
4	海南海药	49.23%	16.03%	5.4分
5	海思科	48.55%	4.01%	6.6分
6	泽璟制药	47.48%	10.30%	6.1分
7	前沿生物	46.86%	19.06%	6.0分
8	石药创新	44.75%	25.45%	5.4分
9	灵康药业	35.27%	6.88%	6.1分
10	贝达药业	32.90%	-0.41%	6.2分
11	圣诺生物	32.90%	8.66%	6.0分
12	-	32.29%	-2.41%	分
13	益方生物	31.18%	20.61%	5.5分
14	亚虹医药	30.35%	32.06%	5.6分
15	首药控股	29.94%	18.59%	5.1分
16	科伦药业	28.72%	13.21%	6.2分
17	富祥股份	27.31%	-9.97%	4.5分
18	赛分科技	26.63%	-4.50%	5.9分
19	京新药业	25.94%	20.50%	5.6分
20	金石亚药	25.36%	0.36%	5.4分
21	信立泰	23.99%	21.39%	6.5分
22	百济神州	22.65%	3.36%	5.5分
23	迪哲医药	22.38%	15.73%	6.4分
24	海欣股份	21.75%	-4.33%	4.4分
25	苑东生物	20.73%	25.34%	5.5分
26	恒瑞医药	20.51%	6.38%	6.3分
27	翰宇药业	20.02%	11.87%	6.6分
28	亨迪药业	19.96%	0.35%	4.5分
29	共同药业	18.98%	9.16%	4.6分
30	汇宇制药	17.69%	19.57%	5.6分
31	华纳药厂	17.42%	20.38%	5.5分
32	奥赛康	16.67%	7.42%	6.3分
33	海辰药业	15.60%	-0.80%	4.2分
34	广生堂	15.34%	-8.08%	5.3分
35	兴齐眼药	15.00%	0.64%	5.0分
36	罗欣药业	14.67%	22.14%	5.6分
37	宣泰医药	14.16%	20.08%	5.2分
38	普洛药业	13.75%	8.22%	6.3分
39	海正药业	13.60%	4.95%	5.5分
40	微芯生物	13.43%	4.60%	5.9分
41	盟科药业	12.56%	10.82%	5.5分
42	金城医药	12.51%	11.69%	6.3分
43	美诺华	12.51%	34.25%	4.7分
44	复旦张江	12.28%	2.85%	5.4分
45	易明医药	11.88%	14.64%	5.5分
46	键凯科技	11.78%	-1.61%	5.6分
47	泰恩康	11.67%	0.88%	4.8分
48	吉贝尔	11.62%	2.11%	4.9分
49	新华制药	11.22%	-2.05%	4.7分
50	一品红	11.21%	3.54%	5.7分
51	千红制药	11.09%	6.44%	6.0分
52	誉衡药业	10.70%	11.11%	6.6分
53	奥锐特	9.60%	4.44%	5.7分
54	华海药业	9.13%	12.01%	6.3分
55	海创药业	8.51%	7.62%	4.5分
56	科源制药	8.29%	-0.08%	5.7分
57	必贝特	7.98%	3.66%	6.1分
58	华东医药	7.82%	3.95%	5.5分
59	丽珠集团	7.14%	5.50%	6.0分
60	复星医药	7.11%	3.20%	5.0分
61	双鹭药业	6.78%	-1.69%	5.1分
62	-	6.73%	16.09%	分
63	-	6.40%	2.88%	分
64	纳微科技	6.31%	-9.46%	5.3分
65	天宇股份	6.30%	2.98%	5.6分
66	健康元	5.30%	5.41%	5.3分
67	润都股份	5.05%	10.04%	4.8分
68	小方制药	4.73%	4.68%	4.6分
69	上海谊众	4.34%	7.66%	5.8分
70	北陆药业	4.31%	4.17%	4.9分
71	ST能特	4.02%	8.88%	5.1分
72	舒泰神	3.95%	3.03%	4.7分
73	华北制药	3.94%	5.15%	4.9分
74	福元医药	3.88%	5.34%	6.0分
75	德展健康	3.64%	3.30%	4.3分
76	威尔药业	3.56%	6.06%	5.6分
77	力生制药	3.34%	2.40%	5.3分
78	诚意药业	3.31%	-0.40%	4.8分
79	-	3.21%	-1.23%	分
80	ST诺泰	3.05%	6.73%	5.0分
81	-	3.02%	7.29%	分
82	东北制药	2.54%	4.72%	4.7分
83	拓新药业	2.34%	9.21%	4.3分
84	ST惠程	2.25%	3.12%	5.2分
85	山河药辅	2.03%	3.17%	4.9分
86	恩华药业	1.91%	5.44%	5.3分
87	-	1.84%	8.13%	分
88	天新药业	1.77%	5.85%	5.6分
89	立方制药	1.73%	6.95%	5.2分
90	卫信康	1.73%	9.44%	5.3分
91	司太立	1.68%	-12.41%	4.4分
92	辰欣药业	1.66%	4.75%	4.9分
93	浙江医药	1.51%	6.14%	4.8分
94	中关村	1.48%	0.00%	4.8分
95	东诚药业	1.37%	0.56%	4.6分
96	凯因科技	1.30%	0.61%	4.5分
97	尔康制药	1.21%	1.21%	4.3分
98	悦康药业	1.03%	6.84%	4.9分
99	海普瑞	0.97%	4.12%	5.8分
100	海森药业	0.69%	3.47%	4.1分
101	仙琚制药	0.48%	2.85%	5.0分
102	川宁生物	0.48%	5.79%	4.7分
103	华特达因	0.41%	-5.82%	4.4分
104	溢多利	0.35%	3.02%	4.7分
105	ST人福	-0.06%	5.11%	5.0分
106	同和药业	-0.15%	4.55%	4.9分
107	亚太药业	-0.18%	0.37%	4.4分
108	华邦健康	-0.24%	4.33%	4.9分
109	-	-0.28%	3.98%	分
110	新天地	-0.32%	5.60%	4.7分
111	华润双鹤	-0.48%	3.68%	5.1分
112	民生健康	-0.57%	0.75%	4.7分
113	海翔药业	-0.75%	-0.38%	5.2分
114	金陵药业	-0.83%	2.57%	5.5分
115	亿帆医药	-0.91%	5.24%	5.6分
116	哈药股份	-1.29%	2.68%	5.1分
117	-	-1.30%	8.55%	分
118	康芝药业	-1.76%	3.90%	3.8分
119	丰原药业	-1.86%	4.34%	5.2分
120	福安药业	-1.93%	5.03%	5.4分
121	赛托生物	-2.05%	6.23%	5.0分
122	哈三联	-2.24%	4.79%	4.5分
123	国邦医药	-2.36%	3.58%	5.8分
124	国药现代	-2.81%	8.81%	5.4分
125	富士莱	-3.67%	4.96%	4.1分
126	新和成	-4.18%	4.01%	5.1分
127	永安药业	-4.98%	3.66%	4.9分
128	本立科技	-5.07%	4.02%	4.4分
129	健友股份	-5.13%	4.53%	5.5分
130	神奇制药	-5.14%	3.83%	5.3分
131	华仁药业	-5.17%	3.63%	4.9分
132	北大医药	-5.24%	3.69%	4.6分
133	ST复华	-5.64%	12.88%	3.7分
134	鲁抗医药	-5.70%	-0.44%	4.2分
135	莱美药业	-5.81%	-8.38%	4.0分
136	九典制药	-5.84%	5.42%	5.0分
137	石药景峰	-5.92%	21.01%	5.6分
138	ST天圣	-6.25%	6.90%	4.9分
139	西点药业	-7.18%	3.00%	4.2分
140	昂利康	-7.42%	4.43%	4.9分
141	向日葵	-8.25%	0.35%	3.4分
142	宏源药业	-8.92%	-9.29%	4.6分
143	联环药业	-8.98%	2.48%	4.4分
144	汉商集团	-9.19%	2.56%	4.7分
145	冀衡医药	-9.67%	5.97%	4.3分
146	中哲精化	-10.27%	1.55%	4.9分
147	仟源医药	-11.10%	1.00%	4.9分
148	奥翔药业	-11.53%	4.13%	4.7分
149	莎普爱思	-11.56%	2.12%	4.1分
150	津药药业	-12.30%	3.31%	4.7分
151	广济药业	-12.60%	1.11%	3.9分
152	-	-13.66%	1.48%	分
153	多瑞医药	-16.47%	5.51%	4.1分
154	东亚药业	-19.23%	-3.51%	5.2分
155	ST南新	-20.67%	2.68%	3.5分
156	博瑞医药	-29.33%	-11.23%	4.6分
157	通化金马	-31.31%	-11.80%	5.5分
158	常山药业	-37.25%	-0.94%	4.4分
159	赛隆退	-97.53%	-5.71%	4.0分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.0基本面打败了55%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（32.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 85/217 ， 139/217。

[{"date":"2026-03-31","value":"1.04","vol":"0.43"},{"date":"2025-12-31","value":"2.49","vol":"-2.03"},{"date":"2025-09-30","value":"3.59","vol":"1.53"},{"date":"2025-06-30","value":"2.72","vol":"1.24"},{"date":"2025-03-31","value":"1.99","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	1.04	2.49	3.59	2.72	1.99
行业(%)	0.43	-2.03	1.53	1.24	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"21.31","vol":"50.72"},{"date":"2025-12-31","value":"22.07","vol":"49.72"},{"date":"2025-09-30","value":"21.71","vol":"49.60"},{"date":"2025-06-30","value":"22.49","vol":"49.57"},{"date":"2025-03-31","value":"20.70","vol":"49.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	21.31	22.07	21.71	22.49	20.70
行业(%)	50.72	49.72	49.60	49.57	49.06

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 94/217 ， 113/217。

[{"date":"2026-03-31","value":"-3.42","vol":"25.51"},{"date":"2025-12-31","value":"-7.49","vol":"38.97"},{"date":"2025-09-30","value":"-0.91","vol":"141.63"},{"date":"2025-06-30","value":"-3.83","vol":"78.56"},{"date":"2025-03-31","value":"-6.95","vol":"0.01"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	-3.42	-7.49	-0.91	-3.83	-6.95
行业(%)	25.51	38.97	141.63	78.56	0.01

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-32.25","vol":"47.13"},{"date":"2025-12-31","value":"-71.54","vol":"-26.11"},{"date":"2025-09-30","value":"-59.32","vol":"-2.93"},{"date":"2025-06-30","value":"-64.38","vol":"59.61"},{"date":"2025-03-31","value":"16.77","vol":"-10.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-32.25	-71.54	-59.32	-64.38	16.77
行业(%)	47.13	-26.11	-2.93	59.61	-10.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 24/217 ， 24/217。

[{"date":"2026-03-31","value":"0.16","vol":"0.10"},{"date":"2025-12-31","value":"0.60","vol":"0.41"},{"date":"2025-09-30","value":"0.52","vol":"0.31"},{"date":"2025-06-30","value":"0.35","vol":"0.21"},{"date":"2025-03-31","value":"0.18","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.16	0.60	0.52	0.35	0.18
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.02","vol":"0.65"},{"date":"2025-12-31","value":"3.29","vol":"2.58"},{"date":"2025-09-30","value":"2.63","vol":"1.93"},{"date":"2025-06-30","value":"1.78","vol":"1.29"},{"date":"2025-03-31","value":"0.93","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	1.02	3.29	2.63	1.78	0.93
行业(次)	0.65	2.58	1.93	1.29	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"10.15","vol":"-2.81"},{"date":"2025-12-31","value":"34.35","vol":"16.49"},{"date":"2025-09-30","value":"-0.43","vol":"4.26"},{"date":"2025-06-30","value":"19.28","vol":"2.95"},{"date":"2025-03-31","value":"1.61","vol":"-26.33"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	10.15	34.35	-0.43	19.28	1.61
行业	-2.81	16.49	4.26	2.95	-26.33

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.75","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.63","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.75	-	0.63	-
行业	0.00	1.60	0.00	1.71	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 37/217 ， 10/217。

[{"date":"2026-03-31","value":"1.53","vol":"3.57"},{"date":"2025-12-31","value":"1.46","vol":"3.31"},{"date":"2025-09-30","value":"1.20","vol":"3.48"},{"date":"2025-06-30","value":"1.25","vol":"3.66"},{"date":"2025-03-31","value":"1.28","vol":"3.57"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.53	1.46	1.20	1.25	1.28
行业	3.57	3.31	3.48	3.66	3.57

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.10","vol":"2.93"},{"date":"2025-12-31","value":"1.07","vol":"2.69"},{"date":"2025-09-30","value":"0.77","vol":"2.73"},{"date":"2025-06-30","value":"0.82","vol":"2.88"},{"date":"2025-03-31","value":"0.83","vol":"2.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	1.10	1.07	0.77	0.82	0.83
行业	2.93	2.69	2.73	2.88	2.80

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 14/217 ， 42/217。

[{"date":"2026-03-31","value":"46.24","vol":"33.54"},{"date":"2025-12-31","value":"47.61","vol":"34.70"},{"date":"2025-09-30","value":"53.44","vol":"34.06"},{"date":"2025-06-30","value":"53.96","vol":"34.12"},{"date":"2025-03-31","value":"54.65","vol":"34.09"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	46.24	47.61	53.44	53.96	54.65
行业(%)	33.54	34.70	34.06	34.12	34.09

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.88","vol":"9.77"},{"date":"2025-12-31","value":"0.93","vol":"1.76"},{"date":"2025-09-30","value":"1.19","vol":"1.19"},{"date":"2025-06-30","value":"1.22","vol":"0.87"},{"date":"2025-03-31","value":"1.25","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.88	0.93	1.19	1.22	1.25
行业(%)	9.77	1.76	1.19	0.87	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"1.38","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.46","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.95","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.12","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[鲁抗医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]